Tuberculosis Diagnostic Trial of CAD4TB Screening Alone Compared to CAD4TB Screening Combined With a CRP Triage Test, Both Followed by Confirmatory Xpert MTB/RIF Ultra in Communities of Lesotho and South Africa
Sponsor: Charite University, Berlin, Germany
This NA trial investigates Tuberculosis and is currently completed. Charite University, Berlin, Germany leads this study, which shows 10 recorded versions since 2022 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
10 versions recorded-
Oct 2025 — Present [monthly]
Completed NA
-
May 2025 — Oct 2025 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Apr 2025 — May 2025 [monthly]
Active Not Recruiting NA
-
Feb 2025 — Apr 2025 [monthly]
Active Not Recruiting NA
-
Nov 2024 — Feb 2025 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 5 earlier versions
-
Sep 2024 — Nov 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Recruiting NA
-
Jan 2023 — May 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2022 — Jan 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Charite University, Berlin, Germany
- Human Sciences Research Council
- Institute of Tropical Medicine, Belgium
- Klaus Reither
- Radboud University Medical Center
- SolidarMed
For direct contact, visit the study record on ClinicalTrials.gov .